exendin-4 glp 1 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway The glucagon-like peptide-1 analogue exendin-4

Unlike FDA-approved medications (e.g., Wegovy, Ozempic, Zepbound), compounded alternatives lack agency review for safety, quality, and efficacy

While these conditions might seem

Bravo to the whole @ro team

Tirzepatide carries an FDA black box warning for risk of thyroid C-cell tumors, including medullary thyroid carcinoma, based on rodent studies, and is contra...

In a TikTok video shared by t...

While prevailing assumptions suggest that improved body image and erectile function, even in people with diabetes, associated with glucagon-like peptide-1 (GLP-1) agonist medications would correlate with heightened sexual function, there is limited ...